This paper will examine the challenges of international compulsory licensing by examining the issue historically and legally as well as offer possible solutions. Thus, this paper will explore the challenge of balancing corporate interests against the affordability and availability of pharmaceuticals by focusing on discrete situations in developing countries, the history of compulsory licensing, and how the World Health Organization (the “WHO”) and the WTO have attempted to tackle these challenges through compulsory licensing, and it will suggest a possible framework for use in arbitration, which balances equities through a Georgia-Pacific analysis.
Finding a Forest Through the Trees: Georgia-Pacific as Guidance for Arbitration of International Compulsory Licensing Disputes,
23 Marq. Intellectual Property L. Rev. 153
Available at: https://scholarship.law.marquette.edu/iplr/vol23/iss2/6
Antitrust and Trade Regulation Commons, Commercial Law Commons, Consumer Protection Law Commons, Dispute Resolution and Arbitration Commons, Food and Drug Law Commons, Health Law and Policy Commons, Intellectual Property Law Commons, International Law Commons, International Trade Law Commons, Science and Technology Law Commons